On or around 05/23/2017 (Stipulation and order of dismissal (voluntary dismissal))
Filing Date: March 13, 2017
According to the Complaint, on February 13, 2017, the Company announced that it had entered into a definitive agreement (the “Merger Agreement”) by which Allergan, through its wholly owned subsidiary, Merger Sub, would acquire Zeltiq through a long-form merger to acquire all of the outstanding shares of Zeltiq for $56.50 per share in cash (the “Proposed Transaction”). The Proposed Transaction is valued at approximately $2.475 billion.
On March 9, 2017, the Company filed a Preliminary Proxy on Schedule 14A (the “Proxy”) with the SEC. The Complaint alleges the Proxy is materially deficient and misleading because it fails to disclose material information about the potential conflicts of interest faced by Company management and the financial projections prepared by Company management relied upon by the Company’s financial advisor.
Pursuant to a stipulation by the parties, this case was ordered dismissed on May 23, 2017.
Company & Securities Information
Defendant: Zeltiq Aesthetics, Inc.
Industry: Medical Equipment & Supplies
Headquarters: United States
Ticker Symbol: ZLTQ
Company Market: NASDAQ
Market Status: Public (Listed)
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
First Identified Complaint
Michael Kreindler, et al. v. Zeltiq Aesthetics, Inc., et al.
COURT: N.D. California
DOCKET #: 17-CV-01353
DATE FILED: 03/13/2017
CLASS PERIOD START: 02/13/2017
CLASS PERIOD END: 03/13/2017
PLAINTIFF FIRMS NAMED IN COMPLAINT:
Levi & Korsinsky (San Francisco) 44 Montgomery Street, Suite 650, Levi & Korsinsky (San Francisco), CA 94104 (415) 291-2420 (415) 484-1294 ·
First Identified Complaint (FIC) Filings:
Class Action Complaint for Violation of the Federal Securities Laws
Stipulation and Order Concerning Plaintiff's Voluntary Dismissal of the Above Action and Plaintiff's Counsel's Anticipated Application for an Award of Attorneys' Fees and Expenses
U.S. District Court Civil Docket
—Reference Complaint Complaint Related Data is not available
Related District Court Filings
—Related District Court Filings Data is not available